ROIV

#518
Roivant Sciences Ltd. - Common Shares
29.9 9 USD
+0.37%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
29.98
30.01
Jahresspanne
0.29
32.79
Tagesänderung
+0.37%
Monatliche Änderung
+7.53%
6 month change
+46.43%
Jahresänderung
+63.79%
Vorheriger Schlusskurs
29.8 8
Open
30.0 1
Tief
29.9 8
High
30.0 1
Volumen
326
Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik
Vierteljährlich Jährlich
Gewinn- und Verlustrechnung Bilanz Cashflow
Wert Q4, 24 TTM

Roivant Sciences Ltd. - Common Shares

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

Nachrichten